FBLG - FibroBiologics, Inc.

QQQ $ 617.59 $ 1.59 (0.26 %)

DIA $ 472.45 $ 2.58 (0.55 %)

SPY $ 677.62 $ 1.15 (0.17 %)

TLT $ 91.53 $ -0.03 (-0.03 %)

GLD $ 380.27 $ 1.71 (0.45 %)

Previous Close

$ 0.4107

Open

$ 0.41

Bid

$ 0.42 x 1,984

Ask

$ 0.42 x 500

Day's Range

$ 0.41 - $ 0.42

52 Week Range

$ 0.39 - $ 3.89

Volume

743,501

Average Volume

Market Cap

17.2M

Beta (5Y Monthly)

$ 0.73

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-31-2025	06-30-2025	10-Q
2	05-14-2025	03-31-2025	10-Q
3	03-31-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-07-2024	06-30-2024	10-Q
6	05-14-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Fibr...
09/12/2025 10:28:47

HC Wainwright & Co. analyst Matthew Caufield reiterates FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $10 price ...

FibroBiologics Announces IND-Enabling Upda...
09/11/2025 12:36:31

D. Boral Capital Maintains Buy on FibroBio...
09/10/2025 15:18:11

D. Boral Capital analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $16 price target.

FibroBiologics Advances Bone Marrow Organo...
09/10/2025 12:35:16

FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued ...

Watching FibroBiologics; Zacks Small-Cap ...
08/05/2025 18:38:42

https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_08052025_FBLG_Bautz.pdf

HC Wainwright & Co. Maintains Buy on Fibro...
08/05/2025 10:30:08

HC Wainwright & Co. analyst Matthew Caufield maintains FibroBiologics (NASDAQ:FBLG) with a Buy and raises the price targ...

D. Boral Capital Maintains Buy on FibroBio...
08/04/2025 11:32:28

D. Boral Capital analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $16 price target.

FibroBiologics, Inc. - Common Stock Q2 EPS...
07/31/2025 21:15:10

FibroBiologics, Inc. - Common Stock (NASDAQ:FBLG) reported quarterly losses of $(0.12) per share which missed the analyst conse...

FibroBiologics H1 2025 Net Loss ~$9.6M
07/31/2025 20:43:10

D. Boral Capital Maintains Buy on FibroBio...
07/29/2025 13:16:15

D. Boral Capital analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $16 price target.

FibroBiologics Files Patent Application Wi...
07/28/2025 12:34:35

D. Boral Capital Maintains Buy on FibroBio...
07/09/2025 14:22:26

D. Boral Capital analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $16 price target.

FibroBiologics Confirms That CYWC628 Spher...
07/09/2025 12:35:10

D. Boral Capital Maintains Buy on FibroBio...
06/17/2025 12:11:07

D. Boral Capital analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $16 price target.

FibroBiologics Announces The Appointment O...
06/09/2025 12:38:33

FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 275+ patents issued ...

D. Boral Capital Maintains Buy on FibroBio...
05/15/2025 17:34:31

D. Boral Capital analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $16 price target.

FibroBiologics, Inc. - Common Stock Q1 EPS...
05/14/2025 20:55:01

D. Boral Capital Maintains Buy on FibroBio...
04/09/2025 11:24:43

D. Boral Capital analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $16 price target.

HC Wainwright & Co. Reiterates Buy on Fibr...
04/01/2025 11:31:06

HC Wainwright & Co. analyst Matthew Caufield reiterates FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $12 price ...

D. Boral Capital Maintains Buy on FibroBio...
04/01/2025 11:04:25

D. Boral Capital analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $16 price target.